Investors are closely watching the US cannabis space after President Donald Trump signaled plans to reschedule marijuana, a move that is expected to unlock near-term financial relief and longer-term
In the last 3-6 months, most marijuana stocks have gone from bottom prices to an upward swing. For a long while, the sector has fallen and lain dormant. This led to much fear and doubt among some shar
Marijuana stocks have begun to gain traction in trading, exhibiting moderate consistency. But why did this occur, and what is happening to bring such momentum to the sector? Once again, the backing an
Canada's Largest Medical Cannabis Company to Launch Two High-Potency Cultivars, Expanding Patient Choice in Australia EDMONTON, ALBERTA , Aug. 12, 2025 /PRNewswire/ - Aurora Cannabis Inc. (NASDAQ: ACB
Cannabis stocks moved sharply higher on reports that President Donald Trump is considering rescheduling marijuana to a less restrictive drug category. The move would see marijuana reclassified from a
Aurora Cannabis reported mixed Q1 FY2026 results, with core medical cannabis sales pressured by regulatory changes and competition. In addition, the company's plant propagation subsidiary experienced
NASDAQ | TSX: ACB EDMONTON, AB , Aug. 8, 2025 /PRNewswire/ - Aurora Cannabis Inc. (the "Company" or "Aurora") (NASDAQ: ACB) (TSX: ACB), a leading Canada-based global medical cannabis company, is pleas
Canada's Largest Medical Cannabis Company to Discuss Strategy, Industry Trends, and Long-Term Growth Outlook EDMONTON, ALBERTA , Aug. 7, 2025 /PRNewswire/ - Aurora Cannabis Inc. (NASDAQ: ACB) (TSX: AC
Aurora Cannabis stock slips after Q1 earnings miss, but revenue climbs 17.5% year over year on strong global medical cannabis demand.
Aurora Cannabis Inc. (NASDAQ:ACB ) Q1 2026 Earnings Conference Call August 6, 2025 8:00 AM ET Company Participants Kevin Niland - Corporate Participant Miguel Martin - CEO & Executive Chairman Simona
Aurora Cannabis Inc. (ACB) came out with a quarterly loss of $0.19 per share versus the Zacks Consensus Estimate of $0.18. This compares to a loss of $0.11 per share a year ago.
NASDAQ | TSX: ACB Expands YoY Global Medical Cannabis Net Revenue 1 by 37% to $64.8 million, while increasing International Medical Cannabis Net Revenue 1 by 85% to $37.1 million Delivers Adjusted EBI
ACB's global medical cannabis momentum stays strong, but near-term regulatory headwinds might have limited Q1 revenue upside.
Currently, the cannabis industry is in another transitional period, presenting both challenges and potential opportunities for investors. After several years of volatility and downward trading, mariju
Your vote is important no matter how many shares you own. Please vote today.
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE